Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System for Cardiac and Respiratory Support: The MOBYBOX Trial

NCT04183660 is registered in ClinicalTrials.gov with Hemovent GmbH as lead sponsor.

NCT NCT04183660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04183660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System for Cardiac and Respiratory Support: The MOBYBOX Trial
Lead sponsor
Hemovent GmbH
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2024
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac failure, cardio-respiratory failure, imminent cardiorespiratory or respiratory failure, respiratory failure